EP1530720A4 - Breast cancer eradication program - Google Patents

Breast cancer eradication program

Info

Publication number: EP1530720A4
Authority: EP; European Patent Office
Prior art keywords: breast cancer; eradication program; cancer eradication; program; breast
Prior art date: 2001-11-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP02780675A

Other languages

German (de)

French (fr)

Other versions

EP1530720A2 (en

Inventor

David A Sirbasku

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Signe BioPharma Inc

Original Assignee

David A Sirbasku

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-13

Filing date

2002-11-13

Publication date

2005-08-31

2002-11-13 Application filed by David A Sirbasku filed Critical David A Sirbasku

2002-11-13 Priority to EP10185007A priority Critical patent/EP2306187A1/en

2002-11-13 Priority to EP10184998A priority patent/EP2299265A1/en

2005-05-18 Publication of EP1530720A2 publication Critical patent/EP1530720A2/en

2005-08-31 Publication of EP1530720A4 publication Critical patent/EP1530720A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP02780675A 2001-11-13 2002-11-13 Breast cancer eradication program Withdrawn EP1530720A4 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
EP10185007A EP2306187A1 (en)	2001-11-13	2002-11-13	Cancer eradication program
EP10184998A EP2299265A1 (en)	2001-11-13	2002-11-13	Cancer eradication program

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33803701P	2001-11-13	2001-11-13
US338037P		2001-11-13
PCT/US2002/036632 WO2003042404A2 (en)	2001-11-13	2002-11-13	Breast cancer eradication program

Publications (2)

Publication Number	Publication Date
EP1530720A2 EP1530720A2 (en)	2005-05-18
EP1530720A4 true EP1530720A4 (en)	2005-08-31

Family

ID=23323133

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
EP10185007A Withdrawn EP2306187A1 (en)	2001-11-13	2002-11-13	Cancer eradication program
EP02780675A Withdrawn EP1530720A4 (en)	2001-11-13	2002-11-13	Breast cancer eradication program
EP10184998A Withdrawn EP2299265A1 (en)	2001-11-13	2002-11-13	Cancer eradication program

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
EP10185007A Withdrawn EP2306187A1 (en)	2001-11-13	2002-11-13	Cancer eradication program

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
EP10184998A Withdrawn EP2299265A1 (en)	2001-11-13	2002-11-13	Cancer eradication program

Country Status (3)

Country	Link
EP (3)	EP2306187A1 (en)
AU (1)	AU2002343714A1 (en)
WO (1)	WO2003042404A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60143320D1 (en)	2000-05-10	2010-12-02	Signe Biopharma Inc	MEANS AND METHODS FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF STEROID HORMONE-RESPONDING CANCER DISEASES
WO2003042404A2 (en)	2001-11-13	2003-05-22	Sirbasku David A	Breast cancer eradication program
WO2010097797A1 (en)	2009-02-27	2010-09-02	No Screw Ltd.	Cutting tool, cutting tool holder and cutting insert therefor
AU2013400082B2 (en) *	2013-09-05	2016-01-28	Profeat Biotechnology Co., Ltd.	Use of composition containing ferrous amino acid chelate in preparation of anti-cancer medicament
TWI483721B (en)	2013-09-05	2015-05-11	Profeat Biotechnology Co Ltd	The use of a composition containing a ferrous amino acid chelate for the manufacture of anti-cancer medicaments
WO2018098804A1 (en) *	2016-12-02	2018-06-07	普惠德生技股份有限公司	Use of composition containing ferrous amino acid chelate for manufacturing pharmaceutical product for preventing cancer metastasis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4393071A (en) *	1975-03-17	1983-07-12	Naoharu Fujii	Method of treating gastric, mammary, lung and uterus tumors
EP0246734A1 (en) *	1986-03-21	1987-11-25	Efamol Holdings Plc	Iron-containing composition and method for treatment of cancer
WO1996040108A1 (en) *	1995-06-07	1996-12-19	Washington University	Multidentate metal complexes and methods of making and using thereof
WO2001086307A2 (en) *	2000-05-10	2001-11-15	Sirbasku David A	Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4683200A (en) *	1984-05-17	1987-07-28	Setsuo Hirohashi	Monoclonal antibody to human cancer antigen and method for producing same
RU1837891C (en) *	1991-01-31	1993-08-30	Keshelava Viktor V	Method for preparation antitumor agent
US6200547B1 (en) *	1994-01-26	2001-03-13	Ferx Incorporated	Magnetically responsive compositions for carrying biologically active substances and methods of production and use
EP1042360A2 (en) *	1997-12-24	2000-10-11	Corixa Corporation	Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO2003042404A2 (en)	2001-11-13	2003-05-22	Sirbasku David A	Breast cancer eradication program

2002
- 2002-11-13 WO PCT/US2002/036632 patent/WO2003042404A2/en not_active Application Discontinuation
- 2002-11-13 EP EP10185007A patent/EP2306187A1/en not_active Withdrawn
- 2002-11-13 AU AU2002343714A patent/AU2002343714A1/en not_active Abandoned
- 2002-11-13 EP EP02780675A patent/EP1530720A4/en not_active Withdrawn
- 2002-11-13 EP EP10184998A patent/EP2299265A1/en not_active Withdrawn

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4393071A (en) *	1975-03-17	1983-07-12	Naoharu Fujii	Method of treating gastric, mammary, lung and uterus tumors
EP0246734A1 (en) *	1986-03-21	1987-11-25	Efamol Holdings Plc	Iron-containing composition and method for treatment of cancer
WO1996040108A1 (en) *	1995-06-07	1996-12-19	Washington University	Multidentate metal complexes and methods of making and using thereof
WO2001086307A2 (en) *	2000-05-10	2001-11-15	Sirbasku David A	Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
US20020006630A1 (en) *	2000-05-10	2002-01-17	Sirbasku David A.	Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
US20020012954A1 (en) *	2000-05-10	2002-01-31	Sirbasku David A.	Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth

Also Published As

Publication number	Publication date
AU2002343714A1 (en)	2003-05-26
EP1530720A2 (en)	2005-05-18
EP2306187A1 (en)	2011-04-06
EP2299265A1 (en)	2011-03-23
WO2003042404A2 (en)	2003-05-22
WO2003042404A3 (en)	2003-12-31

Legal Events

Date	Code	Title	Description
2005-04-01	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-05-18	17P	Request for examination filed	Effective date: 20050110
2005-05-18	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
2005-08-31	A4	Supplementary search report drawn up and despatched	Effective date: 20050714
2006-01-06	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1076150 Country of ref document: HK
2007-04-11	17Q	First examination report despatched	Effective date: 20060303
2007-07-25	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SIGNE BIOPHARMA INC.
2007-07-25	RIN1	Information on inventor provided before grant (corrected)	Inventor name: SIRBASKU, DAVID A.
2007-08-08	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SIGNE BIOPHARMA INC.
2008-07-02	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 35/00 20060101ALN20080528BHEP Ipc: A61F 13/00 20060101ALI20080528BHEP Ipc: A01N 61/00 20060101ALI20080528BHEP Ipc: A61K 31/00 20060101ALI20080528BHEP Ipc: G01N 33/48 20060101AFI20080528BHEP Ipc: A61F 2/00 20060101ALI20080528BHEP Ipc: A01N 37/18 20060101ALI20080528BHEP Ipc: A61K 38/00 20060101ALI20080528BHEP Ipc: A61K 51/00 20060101ALI20080528BHEP Ipc: A61M 36/14 20060101ALI20080528BHEP
2015-06-05	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1076150 Country of ref document: HK
2015-10-02	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2015-11-04	18D	Application deemed to be withdrawn	Effective date: 20150602

Publication	Publication Date	Title
IL251270A0 (en)	2017-06-29	Cancer treatment
AU2002360769A8 (en)	2003-07-30	Breast cancer expression profiling
HK1046344A2 (en)	2003-01-03	Brassieres
GB2380411B (en)	2003-09-03	Breast pumps
GB0110847D0 (en)	2001-06-27	Breast cancer detection
AU2002351374A8 (en)	2003-06-23	Antibodies to treat cancer
GB0005257D0 (en)	2000-04-26	Breast cancer hormonal therapy
EP1530720A4 (en)	2005-08-31	Breast cancer eradication program
EP1401494A4 (en)	2005-02-23	Tumor therapy
GB0026015D0 (en)	2000-12-13	Cancer treatment
AU2002360815A8 (en)	2003-07-24	Human breast cancer biomarkers
EP1463511A4 (en)	2005-09-28	Combination cancer therapy
GB2382019B (en)	2005-03-16	Brassiere
GB2371465B (en)	2002-12-11	Shoe tree
CA96410S (en)	2002-05-31	Breast feeding tee-shirt
CA96409S (en)	2002-05-31	Breast feeding tee-shirt
CA96408S (en)	2002-05-31	Breast feeding tee-shirt
CA94330S (en)	2001-12-31	Breast feeding nightdress
GB0122410D0 (en)	2001-11-07	Cancer diagnosis
GB0123630D0 (en)	2001-11-21	cancer
GB0127668D0 (en)	2002-01-09	Cancer
GB0115673D0 (en)	2001-08-22	Cancer
CA96411S (en)	2002-05-31	Breast feeding bra
TW527869U (en)	2003-04-11	Improved bra
TW511465U (en)	2002-11-21	Improved bra